Privia Health Group, Inc. PRVA
Set alert
21.48 USD -0.52 -2.34%
At close · Oct 30
21.48 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
21.31 Day range 22.10
19.10 52-week range 28.10
- YTD
- -9.41%
- 1 year
- -12.36%
- Open
- 22.10
- Prev close
- 22.00
- Mkt cap
- 2.74B
- Vol
- 841.16K
- Avg vol
- 1.23M
- EPS
- 0.21
- P/E
- 102.29
- Div yield
- 0.00%
More statistics
- Low
- 21.31
- High
- 22.10
- Forward P/E
- 20.21
- Beta
- 0.80
- Short ratio
- 3.57
- Inst. own
- 99.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 20.87
- 200-d avg
- 22.67
- 1y target
- 31.47
6M chart
Events in this range
- May 7, 2026Earnings: 0.02; estimate 0.08; surprise -75%
- May 8, 2026Rating: Canaccord Genuity · Buy → Buy
- May 26, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Aug 6, 2026Earnings: 0.07; estimate 0.06738; surprise 3.89%
Signals (37)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 2026 | 2 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| RSI: Oversold | Aug 26, 2026 | 2 months ago |
| RSI: Oversold | Aug 20, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| RSI: Oversold | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| RSI: Oversold | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| MACD: Sell Signal | May 6, 2026 | 5 months ago |
Key statistics
- Market cap
- 2.74B
- Enterprise value
- 2.46B
- Trailing P/E
- 102.29
- Forward P/E
- 20.21
- PEG ratio
- 0.00
- Price / sales
- 1.16
- Price / book
- 3.47
- EPS (TTM)
- 0.21
- Beta
- 0.80
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.19%
- Revenue (TTM)
- 2.36B
- Revenue growth
- 21.40%
- Free cash flow
- 95.65M
- Total cash
- 412.20M
- Total debt
- 8.73M
- Return on equity
- 4.31%
- Shares outstanding
- 127.73M
- Short % of float
- 5.81%
- 50-day average
- 20.87
- 200-day average
- 22.67
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 31.47 +46.5% upside
Now 21.48
- Target (low)
- 24.00
- Target (mean)
- 31.47
- Target (high)
- 40.00
Ratings (0m) 18 17 buy · 1 hold · 0 sell
- Strong buy5
- Buy12
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.238.
Financials — quick view
PRVA Revenue — quarterly 632.63M
PRVA Net income — quarterly 9.05M
PRVA EPS — quarterly 0.07
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.09055 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.06738 | 0.07 | 0.00 | +3.89% |
| May 7, 2026 | Mar 31, 2026 | 0.08 | 0.02 | -0.06 | -75.00% |
| Feb 26, 2026 | Dec 31, 2025 | 0.04 | 0.07 | +0.03 | +75.00% |
| Nov 6, 2025 | Sep 30, 2025 | 0.06 | 0.05 | -0.01 | -16.67% |
| Aug 7, 2025 | Jun 30, 2025 | 0.05 | 0.02 | -0.03 | -60.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 26, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| May 8, 2026 | Canaccord Genuity | main | Buy | Buy |
| Apr 8, 2026 | Evercore ISI Group | main | Outperform | Outperform |
| Mar 25, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Mar 3, 2026 | Citigroup | main | Buy | Buy |
| Mar 2, 2026 | Truist Securities | main | Buy | Buy |
About Privia Health Group, Inc.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- priviahealth.com
News
- Full Transcript: Privia Health Gr Q2 2026 Earnings Call
- CORRECTION: Privia Health Gr Q2 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate
- Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.422B Est
- Top 3 Health Care Stocks That May Implode This Month
- Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34
- Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.469B Est
- Privia Health Gr Q1 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $603.800M Beat $580.654M Estimate
- Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26
- Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25
- Breaking Down Privia Health Gr: 5 Analysts Share Their Views
Your note
Sign in to keep a note on PRVA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COCOZZA NANCY G | Director | Stock Award(Grant) | May 19, 2026 | 42,814 |
| FARGIS EDWARD C. | General Counsel | Stock Award(Grant) | Mar 9, 2026 | 111,979 |
| KING DAVID P | Director | Stock Award(Grant) | May 19, 2026 | 50,775 |
| MARYLAND PATRICIA ANNE | Director | Stock Award(Grant) | May 20, 2025 | 42,312 |
| MCCARTHY THOMAS A | Director | Stock Award(Grant) | May 19, 2026 | 69,470 |
| MEHROTRA PARTH | Chief Executive Officer | Sale | May 11, 2026 | 434,357 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.76% | 21,402,417 | 459.72M | Jun 29, 2026 |
| FMR, LLC | 10.06% | 12,848,437 | 275.98M | Jun 29, 2026 |
| Durable Capital Partners Lp | 9.11% | 11,635,948 | 249.94M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.15% | 6,572,384 | 141.17M | Jun 29, 2026 |
| Rubicon Founders LLC | 4.67% | 5,971,079 | 128.26M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.04% | 5,156,720 | 110.77M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 7,604,455 | 163.34M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.81% | 3,589,974 | 77.11M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.44% | 3,111,835 | 66.84M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.04% | 2,599,416 | 55.84M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.18% | 1,501,521 | 32.25M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.06% | 1,359,812 | 29.21M | Jun 29, 2026 |